This clinical trial compares the effect of adding motivational self-help materials to usual care smoking cessation resources versus usual care cessation resources alone in patients with a diagnosis of cancer who use tobacco products. Cigarette smoking is involved in multiple cancer types and is responsible for over 30% of cancer deaths in the United States. In addition, smoking affects cancer treatment outcomes and prognosis, regardless of cancer type. A cancer diagnosis represents a teachable moment and can motivate some patients to quit smoking. However, only about 36% of smokers successfully quit after a diagnosis of cancer. Giving motivation self-help materials may help patients with a diagnosis of cancer better understand the impact of the use of tobacco products as well as help more patients quit smoking.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06484179.
Locations matching your search criteria
United States
Utah
Salt Lake City
Huntsman Cancer Institute/University of UtahStatus: Active
Contact: Ursula Martinez Pradeda
Phone: 801-213-2103
PRIMARY OBJECTIVES:
I. To pilot test a self-help intervention to examine the feasibility of randomized controlled trial (RCT) procedures, and to establish confidence intervals of estimated efficacy in increasing smoking cessation motivation compared to usual care among patients with cancers not widely recognized as smoking-related.
II. To conduct formative evaluation to assess contextual factors to inform future intervention implementation into routine care.
OUTLINE:
STUDY I: Patients are randomized to 1 of 2 groups.
GROUP I: Patients receive advice to quit using tobacco and/or a referral to a state quitline or other resources per usual care on study. Additionally, patients may undergo collection of breath samples during follow up.
GROUP II: Patients receive advice to quit using tobacco and/or a referral to a state quitline or other resources per usual care as well as motivational self-help materials about their cancer diagnosis and the use of tobacco products on study. Additionally, patients may undergo collection of breath samples during follow up.
After completion of study intervention, patients are followed up at 2 weeks and 1 month.
STUDY II: Key stakeholders complete questionnaires and interviews on study.
Trial PhaseNo phase specified
Trial Typeprevention
Lead OrganizationHuntsman Cancer Institute/University of Utah
Principal InvestigatorUrsula Martinez Pradeda
